Synosia Therapeutics

closed

Launch date

2006

Market cap

Enterprise valuation

Basel Canton of Basel-Stadt (HQ)

Date	Investors	Amount	Round
Mar 2006	N/A	$2.5m	Series A
Jan 2007	5AM Ventures Novo Holdings Versant Ventures	$32.5m	Late VC
Jan 2009	Novo Ventures 5AM Ventures Aravis Ventures Versant Ventures Swiss Helvetia Fund Investor Growth Capital	$29.0m	Series B
Oct 2010	5AM Ventures Aravis Ventures UCB Pharma Novo Holdings Versant Ventures Swiss Helvetia Fund Investor Growth Capital	$30.0m	Series C
Jan 2011	Biotie Therapies	$122m	Acquisition
Total Funding		$94.0m

Recent News about Synosia Therapeutics